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Abstract 
Background 
Clinical practice guidelines are developed to improve the quality of healthcare. However, 
clinical guidelines may contribute to health inequities experienced by disadvantaged groups. 
This study uses an equity lens developed by the International Clinical Epidemiology Network 
(INCLEN) to examine how well clinical guidelines address inequities experienced by 
individuals with intellectual disabilities. 
Methods 
Nine health problems relevant to the health inequities experienced by persons with 
intellectual disabilities were selected. Clinical guidelines on these disorders were identified 
from across the world. The INCLEN equity lens was used as the basis for a purpose-
designed, semistructured data collection tool. Two raters independently examined each 
guideline and completed the data collection tool. The data extracted by each rater were 
discussed at a research group consensus conference and agreement was reached on a final 
equity lens rating for each guideline. 
Results 
Thirty-six guidelines were identified, one of which (2.8%) explicitly excluded persons with 
intellectual disabilities. Of the remaining 35, six (17.1%) met the first criterion of the equity 
lens, identifying persons with intellectual disabilities at high risk for the specific health 
problem. Eight guidelines (22.9%) contained any content on intellectual disabilities. Six 
guidelines addressed the fourth equity lens criterion, by giving specific consideration to the 
barriers to implementation of the guideline in disadvantaged populations. There were no 
guidelines that addressed the second, third, and fifth equity lens criteria. 
Conclusions 
The equity lens is a useful tool to systematically examine whether clinical guidelines address 
the health needs and inequities experienced by disadvantaged groups. Clinical guidelines are 
likely to further widen the health inequities experienced by persons with intellectual 
disabilities, and other disadvantaged groups, by being preferentially advantageous to the 
general population. There is a need to systematically incorporate methods to consider 
disadvantaged population groups into the processes used to develop clinical guidelines. 
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Introduction 
International health policy is focused on tackling health inequalities [1]. However, the 
evidence suggests that public health interventions have not reduced inequalities [2], and the 
extent of health inequalities may be increasing [3,4]. 
The terms inequalities, disparities, and inequities have been used differently across 
geographical settings and specialities. Since the terms inequalities and disparities are used 
interchangeably, we will use inequalities in this paper. In this paper, we use the definitions of 
health inequalities and inequities provided by Whitehead [5]. Health inequalities refer to 
“measurable difference in health experience in health outcomes between different population 
groups – according to socio-economic status, geographical area, age, disability, gender or 
ethnic group.” Whitehead’s original definition of health equity has been adapted by the 
World Health Organisation (WHO) Commission on the Social Determinants of Health 
(CSDH), who define it as, “the absence of unfair and avoidable or medial differences on 
health amongst social groups” [6]. Health inequalities is the term most commonly used in 
intellectual disabilities research. Therefore, we will use the term inequalities when referring 
to previous intellectual disabilities research. Research and policy relevant to clinical 
guidelines most often refer to equity. Therefore, the terms equity and inequity will be used 
when referring to clinical guidelines, and thereafter in the Methods, Results, and Discussion 
sections of this manuscript. 
Individuals with intellectual disabilities have consistently been reported to experience 
significant health inequalities [7-10]. Individuals with intellectual disabilities have been 
found in research studies to have increased mortality rates and reduced life expectancy [8], 
higher prevalence and incidence of specific physical [11] and mental health [12] needs, and 
poor access to evidence-based healthcare [13]. 
Clinical guidelines aim to improve the quality of healthcare and patient outcomes by 
systematically evaluating the evidence base and contributing to cost-effective healthcare [14]. 
Clinical guidelines have been proposed as one method to address inequalities in healthcare 
[15], and some national guideline organizations explicitly state in their policies that they 
consider health inequalities in the process used to select the topics for guideline development 
[16,17]. However, it has also been suggested that clinical guidelines increase the health 
inequities experienced by disadvantaged subgroups by differentially improving the health of 
people with an existing health advantage [8,18,19]. 
The aim of this study was to examine whether clinical guidelines address the health 
inequalities experienced by people with intellectual disabilities. Three research questions 
were examined: 
1. Do clinical guidelines identify individuals with intellectual disabilities as a group who are 
at increased risk of the disorder? 
2. Do clinical guidelines include content relevant to the specific health needs of persons with intellectual disabilities (i.e., statements and recommendations)? 
3. Do guideline development processes take into consideration the specific health needs of persons with intellectual disabilities? 
Methods 
Measurements 
The International Clinical Epidemiology Network (INCLEN) supports the role that clinical 
guidelines can have in influencing practice and potentially reducing health inequities. To 
support groups developing clinical guidelines that address health inequities, INCLEN 
developed an “equity lens” to evaluate how well a clinical guideline addresses issues of 
equity [20]. This was one of 16 papers published by INCLEN as part of a program of work to 
advise the WHO Advisory Committee on Health Research on clinical guidelines. The five 
criteria of the equity lens and guidance on what to look for in clinical guidelines, as evidence 
for each of the five criteria [20], are shown in Table 1. 
Table 1 The INCLEN equity lens [20] 
INCLEN = International Clinical Epidemiology Network 
Equity lens criteria What evidence for the criteria to look for in clinical guidelines 
1. Do the public health recommendations in the guidelines address a 
priority problem for disadvantaged populations? 
Discussions on the burden of disease in disadvantaged populations. 
2. Is there a reason to anticipate different effects of intervention in 
disadvantaged and privileged populations? 
Discussions on differences between disadvantaged and privileged 
populations, in terms of biology of the disease, adherence, and 
baseline risks. 
3. Are the effects of the intervention valued differently by 
disadvantaged compared to privileged populations? 
Values may be assessed in guideline development panels through 
consultations with disadvantaged populations, involvement of their 
caregivers, reference to relevant research, or transparent reflection. 
4. Is specific attention given to minimizing barriers to 
implementation in disadvantaged populations? 
Discussion of barriers to implementation in disadvantaged 
populations and identification of strategies to overcome these 
barriers. 
5. Do plans for assessing the impact of the recommendations 
include disadvantaged populations? 
Plans for monitoring disadvantaged groups according to place of 
residence, race, occupation, gender, religion, education, 
socioeconomic status, or social network and capital. 
This study used the INCLEN equity lens to examine whether existing clinical guidelines 
address the health inequities experienced by people with intellectual disabilities. We also 
looked in more detail at the information provided on the guideline development process to 
identify potential means to address the health inequities experienced by individuals with 
intellectual disabilities and other disadvantaged groups. 
To answer the research questions, the INCLEN equity lens was used to inform the design of a 
semistructured data collection tool, to extract information from the guidelines. Additional 
questions to look in more detail at the guideline development process and the content of 
guidelines were inserted. The data collection tool was divided into three sections: 
1. Population relevance: 
• Are any population groups, and specifically persons with intellectual disabilities, 
excluded from the guideline remit? 
• Are groups at high risk of a disorder and, specifically, are persons with intellectual 
disabilities identified (equity lens criterion one)? 
2. Guideline content: 
• Are statements relevant to the specific health needs of individuals with intellectual 
disabilities made? Statements were divided into four categories: diagnosis and intervention 
(equity lens criteria two and three), guideline implementation (equity lens criteria four and 
five), and a category for other statements. 
• Are recommendations specific to the health needs of individuals with intellectual 
disabilities made? 
3. Guideline development process: 
• Is an expert in intellectual disabilities included in the guideline development group? 
• Is there evidence that the design of the literature search strategy could identify studies 
relevant to intellectual disabilities, for example, the use of relevant search terms or the 
citation of specific references relevant to intellectual disabilities? 
• Is there evidence of consultation with people with intellectual disabilities and /or their 
carers in the development and implementation of the guideline (equity criterion three)? 
Selection of clinical guidelines 
To meet the aim of the study, it was necessary that clinical guidelines on these disorders 
could meet at least one, or more, of the equity lens criteria. In the description of this first 
equity criterion [20], it is suggested that a problem is a priority for a disadvantaged group if 
there is an increased burden of disease and/or the prevalence of the disorder is higher in the 
disadvantaged group. To ensure that clinical guidelines could potentially address the 
inequities experienced by individuals with intellectual disabilities, we examined clinical 
guidelines on disorders known to have a higher prevalence in persons with intellectual 
disabilities. For example, it is known that there is research evidence from population-based 
epidemiological studies that obesity has a higher prevalence in individuals with intellectual 
disabilities. A clinical guideline on obesity could, therefore, potentially meet the first equity 
criterion with reference to intellectual disabilities. 
On this basis, we selected nine health problems with research evidence from population-
based, epidemiological studies demonstrating higher rates of these disorders in individuals 
with intellectual disabilities [11,13,21]. Intellectual disabilities’ psychiatry and psychology 
are established clinical specialties, internationally. Therefore, we considered that it may be 
more likely for clinical guidelines on mental health disorders to address the health inequities 
of individuals with intellectual disabilities. To take account of this, the list included disorders 
of physical and mental health. The health problems selected were obesity, osteoporosis, 
epilepsy, obstructive sleep apnea, upper gastrointestinal disorders, accidents/injuries or falls, 
bipolar affective disorder, dementia, and schizophrenia. 
Since clinical guideline development is of relevance to health inequities globally, the 
inclusion of guidelines published in different countries was felt to be important. The National 
Guideline Clearing House lists guidelines produced worldwide so was used to identify a 
representative sample of relevant clinical guidelines (www.guideline.gov). 
To improve the quality of clinical guidelines, organizations producing clinical guidelines are 
recommended to follow standardized procedures throughout the guideline development 
process. For example, there can be explicit requirements on the composition of the guideline 
development group or search strategies used. This standardized approach can be a potential 
strength of organizations with responsibility for the development of all clinical guidelines in a 
single country. Despite this standardization, we recognized that inclusion of a single 
guideline from a national organization could not be considered representative. On the other 
hand, no national organizations were identified as having published clinical guidelines on all 
nine health problems of relevance to this study. Therefore, to include guidelines of 
international relevance, while also attempting to include guidelines reflecting standardized 
procedures, it was decided to limit the sample to clinical guidelines published in English, 
from countries with guidelines available for two or more of the nine health problems selected 
(see Table 2). 
Table 2 Countries and organizations with clinical guidelines on the selected topics (see 
Additional file 1) 
 Country 
Epilepsy  UK    SIGN (original 2003, update 2005, review 2007)  
    NICE (2004) 
Singapore Ministry for Health (2007) 
  
Obesity UK    SIGN (2010) 
    NICE (2006) 
Australia  National Health & Medical Research Council (2003) 
USA   National Heart, Lung & Blood Institute (1998) 
Canada  Canadian Medical Association (2007) 
Malaysia  Ministry for Health (2004) 
 
Osteoporosis    UK   SIGN (original 2003, update 2004, review 2007) 
USA    American College of Physicians (2008) 
Canada  Society of Obstetricians & Gynaecologists of Canada (2009) 
Singapore Singapore Ministry of Health (2009) 
Malaysia  Malaysian Ministry of Health (2003) 
 
Dementia UK    SIGN (original 2006, review 2009) 
     NICE (2007) 
NZ    Ministry of Health (1997) 
USA   American Psychiatric Association (2007) 
Canada  Canadian Medical Association (2008) 
Singapore Ministry of Health (2007) 
 
Schizophrenia UK    SIGN (original 1998, review 2005) 
    NICE (2009) 
NZ    Royal Australian & New Zealand College of Psychiatrists (2004) 
Australia  same as New Zealand 
Canada  Canadian Psychiatric Association (2005) 
 
Upper 
gastrointestinal 
problems  
UK   SIGN (original 2003, review 2009) 
     NICE (2004) 
NZ    New Zealand Guidelines Group (2004) 
Canada  Canadian Medical Association (June 2000, update Sept 2000) 
 
Accidents/injuries  
& falls  
UK   NICE (2004) 
Canada  Canadian Task Force on Preventive Health Care (June 2003) 
 
Bipolar disorder  UK   SIGN (original 2005, review 2009) 
    NICE (2006) 
NZ    Royal Australian & New Zealand College of Psychiatrists (2004)   
Australia same as New Zealand                       
Canada  Canadian Network for Mood & Anxiety Treatments (2005, update 2007) 
       
Obstructive sleep   
apnea    
UK   SIGN (original 2003, review 2009) 
USA   American Academy of Sleep Medicine 2006 
 
SIGN = Scottish Intercollegiate Guideline Network; NICE = National Institute for Health and 
Clinical Excellence 
Data extraction process 
All of the guidelines were independently searched electronically by two medically qualified 
doctors (LAMM and MLM) to identify any content of specific relevance to intellectual 
disabilities. Since there are several different terms for intellectual disabilities used 
internationally, individual search terms used to identify relevant content included disability, 
disabilities, retardation, impairment, handicap, intellectual, learning, and mental. The two 
doctors independently completed the data extraction tool for each guideline. The data sets 
produced by the independent raters were systematically discussed at a consensus meeting of 
the research team. If there were any discrepancies between raters, the section of the guideline 
in question was re-examined by the research team to reach consensus agreement for each 
guideline. 
In extracting data relevant to the first equity lens criterion, we wanted to examine whether 
guidelines did not see the identification of high-risk groups as part of the guideline remit or 
whether they were including information on some high-risk groups and omitting intellectual 
disabilities. To achieve this, the raters scored guidelines on whether the guideline identified 
any population group at high risk of the health problem, and then separately scored whether 
the guideline identified individuals with intellectual disabilities at high risk. 
Results 
The 36 guidelines in Table 2, from seven countries, met the inclusion criteria for the study 
(Additional file 1). 
One of the guidelines (2.8%) explicitly excluded persons with intellectual disabilities. Of the 
remaining 35, six (17.1%) met the first criterion of the equity lens, identifying persons with 
intellectual disabilities at high risk for the specific health problem. 
Equity lens criteria 
As described above, the study design meant that all 36 guidelines could potentially meet the 
first equity lens criteria for intellectual disabilities. Although 29 guidelines (82.9%) met the 
first equity lens criteria by identifying population subgroups at increased risk for this specific 
disorder, only six of these (71.1%) identified people with intellectual disabilities at increased 
risk of the disorder (Table 3). Therefore, although the majority of guidelines met this criterion 
to some extent, relatively few did so with regard to intellectual disabilities. The section 
examining the guideline development process (see below) suggests possible reasons for the 
inconsistency with which guidelines meet the first equity lens criteria for disadvantaged 
groups. 
Table 3 Guidelines meeting equity lens criteria or containing additional content on intellectual disabilities 
 
Equity lens criterion 1 Equity lens criterion 4 
(number of comments) 
Non-lens ID statement categories 
(number of comments) 
 
Any groups 
identified at 
increased risk 
ID identified 
at increased 
risk 
Barriers to 
implementation 
Diagnosis Intervention Other 
Obesity SIGN 
NICE 
Australia 
USA 
Canada 
Malaysia 
NICE 
SIGN 
NICE (5) SIGN (1) NICE (6)  
SIGN (1)  
NICE (4) 
SIGN (2) 
Osteoporosis SIGN 
USA 
Canada 
Singapore 
 
None None None None 
Epilepsy NICE 
SIGN 
SIGN 
NICE 
NICE (5) 
SIGN (9) 
NICE (18) 
SIGN (3) 
NICE (12) 
SIGN (6) 
NICE (19) 
SIGN (5) 
Obstructive sleep 
apnea 
SIGN 
USA 
 
None None None None 
Upper 
gastrointestinal 
problems 
NICE 
New Zealand 
Canada 
 
None None None None 
Accidents/injuries, 
falls 
NICE 
Canada 
 
None None None None 
Dementia NICE 
USA 
Canada 
Singapore 
Malaysia 
NICE NICE (10) NICE (9) NICE (9) NICE (4) 
Schizophrenia New Zealand/ 
Australia 
 
None Canada (1) None None 
Bipolar affective SIGN NICE NICE (1) NICE (1) None NICE (1) 
disorder NICE 
Canada 
SIGN (1) SIGN (1) 
ID = intellectual disabilities; SIGN = Scottish Intercollegiate Guideline Network; NICE = National Institute for Health and Clinical Excellence 
Five guidelines (shown in Table 3) made some statement about the barriers to 
implementation of the guideline for persons with intellectual disabilities and were rated as 
meeting equity lens criterion number four. The potential barriers to implementation 
recognized in the guidelines included the need to consider the decision-making capacity of 
health service users, problems individuals with intellectual disabilities experience accessing 
generic healthcare services, and challenges faced when service users make the transition from 
children to adult’s services. 
None of the guidelines were rated as addressing equity lens criteria two, three, or five. 
Guideline content 
In order to look beyond the equity lens criteria, we examined the 35 guidelines for all content 
relevant to specific needs of people with intellectual disabilities. Eight guidelines (22.9%) 
contained any content making specific reference to intellectual disabilities. Of these eight, 
seven (20%) contained statements on diagnosis (e.g., descriptions of different presentations in 
intellectual disabilities’ populations, specific diagnostic challenges), five (14.3%) included 
content relevant to interventions (e.g., the need to develop care plans accommodating the 
needs of individuals with intellectual disabilities), and seven (20%) included other relevant 
content (e.g., making reference to the lack of evidence available for the intellectual 
disabilities population). The Scottish Intercollegiate Guideline Network (SIGN) obesity 
guideline included an appendix listing useful resources for professionals working with 
individuals with intellectual disabilities or communication difficulties. 
Specific intellectual disabilities recommendations were made in six guidelines (17.1%). As 
shown in Table 4, none of these were evidence-based recommendations, and most often, the 
recommendations emphasize the need for appropriate specialist referral. 
Table 4 Guidelines with recommendations specific to persons with intellectual 
disabilities 
Theme  Guidelines Specific examples of recommendations 
Specialist management  NICE Obesity 
NICE Epilepsy 
SIGN Epilepsy  
NICE Dementia  
People with learning disabilities and those 
supporting them should have access to specialist 
advice and support regarding dementia. (NICE 
Dementia)  
Communication/consultation  NICE Obesity  
SIGN Epilepsy  
Information in an accessible form should be 
available to clients and carers. (SIGN Epilepsy) 
Equality NICE Epilepsy  
NICE Dementia  
NICE Bipolar  
Every therapeutic option should be explored in 
individuals with epilepsy in the presence or 
absence of learning disabilities. (NICE 
Epilepsy) 
Service/training issues  NICE Dementia  Health and social care staff working in care 
environments where younger people are at risk 
of developing dementia, such as those catering 
to people with learning disabilities, should be 
trained in dementia awareness. (NICE 
Dementia) 
Diagnostic issues  NICE Epilepsy  
NICE Dementia  
Patients with mental retardation, especially 
those who are nonverbal, may be more 
Canada Schizophrenia  challenging to assess; collateral information 
from caregivers is important. Cognitive and 
functional testing to delineate the patient’s 
developmental level and relative strengths and 
weaknesses are also essential. (Canada 
Schizophrenia) 
Treatment issues NICE Epilepsy 
SIGN Epilepsy  
In making a management plan for an individual 
with learning disabilities and epilepsy, particular 
attention should be paid to the possibility of 
adverse cognitive and behavioral effects of anti-
epileptic drug therapy. (NICE Epilepsy) 
SIGN = Scottish Intercollegiate Guideline Network; NICE = National Institute for Health and 
Clinical Excellence 
Guideline development process 
Four (11.4%) of the 35 guideline development groups included members with intellectual 
disabilities expertise. An intellectual disabilities dietician was on the specialist review panel 
for the SIGN obesity guideline but was not part of the development group. 
This lack of expertise in the development guideline groups may, in part, explain the small 
number of guidelines identifying individuals with intellectual disabilities at high risk (equity 
criterion one) or making specific reference to intellectual disabilities anywhere in the 
guideline. This effect could have been compounded by the fact that only two (5.7%) of the 
guidelines contained evidence that the literature search strategy had included search terms 
that would have identified evidence relevant to the health needs of individuals with 
intellectual disabilities (NICE obesity and NICE epilepsy). Although several guidelines that 
did not use specific intellectual disabilities search terms included references relevant to 
intellectual disabilities in the bibliography (NICE obesity, NICE epilepsy, SIGN epilepsy, 
NICE dementia, and NICE bipolar affective disorder), it could be that the methodology used 
to identify relevant evidence does not readily identify intellectual disabilities research. One 
final point of note from the examination of the guideline development process is that only 
one guideline (SIGN epilepsy) carried out consultations with service users and service users 
with intellectual disabilities and carers. 
Discussion 
This is the first study to examine whether clinical guidelines address the health inequities 
experienced by individuals with intellectual disabilities. We found that the majority of 
clinical guidelines did not contain content relevant to intellectual disabilities or meet any of 
the equity lens criteria for intellectual disabilities. Since there is available evidence to allow 
all the guidelines to meet equity lens criterion one, the findings of this study suggest that 
current guideline development processes may be missing an important opportunity to address 
the inequities experienced by individuals with intellectual disabilities. For example, none of 
the guidelines on osteoporosis, obstructive sleep apnea, upper gastrointestinal problems, and 
accidents/injuries or falls identified individuals with intellectual disabilities as being at 
increased risk. If this had been included in the guidelines, it could have led to better 
assessment and diagnosis of those health problems that individuals with intellectual 
disabilities are at high risk of experiencing. Appropriate diagnosis and management would 
subsequently be expected to reduce the inequities experienced by persons with intellectual 
disabilities by allowing fairer access to relevant management and services. 
Strengths and limitations 
This study benefited from the use of the INCLEN equity lens, developed by a group of 
international experts, independent of the research group involved in this study. We found that 
the five equity lens criteria provided a useful framework to consider whether clinical 
guidelines address the inequities experienced by individuals with intellectual disabilities. The 
use of the equity lens as the basis of the study ensures that the process can be repeated in 
future intellectual disabilities studies and studies examining the relevance of clinical 
guidelines to other disadvantaged groups. 
The process used to rate the clinical guidelines was a strength of this study. Three separate 
aspects of the process reduced the risk of rater error: independent rating of the guidelines by 
two researchers, use of a standardized data extraction tool, and a consensus group process to 
agree on final ratings for each guideline. To further improve the rigor of the rating process, 
any future studies could consider blinding the researchers and consensus process to which 
guideline was being rated. 
Since clinical guidelines are of international significance to the inequities experienced by 
individuals with intellectual disabilities, the inclusion of guidelines from different countries 
adds to the relevance of the findings. The development of guidelines is highly complex and 
influenced by multiple factors at any one time. A potential weakness of the study is that the 
research group has little experience of the complexities surrounding the guideline 
development process used across the organizations that produced the guidelines included in 
this study. The study is exploratory in nature and will hopefully allow equity to be considered 
further as part of guideline development. However, future studies of this nature would benefit 
from involvement of international experts in clinical guideline development. 
Improving the equity of clinical guidelines for intellectual disabilities 
Several of the guidelines reviewed illustrate that it is possible to improve the equity of 
clinical guidelines in relation to intellectual disabilities. For example, five guidelines made 
statements on the barriers to implementation (Table 3). This suggests that there are feasible 
changes that can be made to the clinical guideline development process to address inequities. 
INCLEN used the PROGRESS framework shown in Table 5 [22] to identify disadvantaged 
groups that the guideline equity lens should be focused on. The PROGRESS framework has 
been used to examine the equity of systematic reviews [23]. Subsequently, PROGRESS-Plus 
(Table 5) has been proposed as a more comprehensive listing of population subgroups at risk 
of experiencing health inequities [24]. Therefore, guideline development groups could use the 
PROGRESS-Plus framework as part of the processes used to produce clinical guidelines. 
Given the exploratory nature of this study and the complexity of developing guidelines, it is 
not our intention to be prescriptive about how organizations make use of the PROGRESS-
Plus framework. Any decisions on changes in the guideline development process can only be 
made in the context of national policies and priorities. For the purpose of illustration, one 
example would be for national guideline organizations to maintain a list of individuals with 
expert knowledge on intellectual disabilities. Prior to the start of the guideline development 
process, the guideline organization could seek the opinion of a relevant expert on whether 
there is potential for the guideline on a specific topic to address inequities. This would then 
allow the guideline organization to consider the feasibility of adjusting the guideline 
development process to meet the equity lens criteria. 
Table 5 The PROGRESS framework and additional items included in PROGRESS-Plus 
PROGRESS [22] Plus [24] 
Place of residence Age 
Race Disability 
Occupation Sexual orientation 
Gender Other vulnerable groups 
Religion  
Education 
Socioeconomic status 
Social network and capital 
Previous studies that examined the equity of guidelines regarding gender [25] and ethnicity 
[26] made suggestions on how a guideline development process can be adapted to consider 
the needs of these specific groups. The majority of these considerations could also be used for 
other groups listed in the PROGRESS-Plus framework, including people with intellectual 
disabilities. In Table 6, we suggest reasonable adjustments that organizations can make to the 
guideline development process in order to improve the equity of guidelines in relation to 
intellectual disabilities. As stated above, we lack the necessary expertise to make statements 
on necessary changes that organizations should make, internationally. Instead, the 
suggestions in Table 6 are provided as examples of changes that could improve the equity of 
guidelines for individuals with intellectual disabilities. We recognize that such changes have 
resource implications and organizations are best placed to consider the feasibility of 
amendments to the guideline development process. 
Table 6 Reasonable adjustments to support guideline development processes to improve 
the equity of clinical guidelines for individuals with intellectual disabilities 
1. Clinical guideline organizations 
a) Develop an organizational statement that all guideline development groups will specifically 
consider intellectual disabilities and make reasonable adjustments to improve guideline 
equity 
b) Introduce a procedure for a relevant expert on intellectual disabilities to review all topics 
selected for guideline development and, where appropriate, advise the development group 
c) Develop a literature search strategy relevant to intellectual disabilities for use along with 
topic-specific search strategies 
2. Clinical guideline development groups 
a) Where appropriate, make use of the intellectual disabilities literature search to consider how 
the clinical guideline can address those equity lens criterion of relevance 
b) In formulating recommendations, consider how applicable they are to the health of 
individuals with intellectual disabilities, and suggest reasonable adjustments in appendices 
on the equity of guideline implementation 
c) Invite stakeholders relevant to intellectual disabilities to participate in the consultation 
process on draft versions of guidelines 
d) Publish easy-to-read versions for service users, in parallel with the full guideline 
The potential solutions shown in Table 6, or suggested in previous studies [25,26], would 
have a greater impact if they were taken forward by the international collaborations that exist 
to influence the rigor and quality of published clinical guidelines, such as the Guideline 
International Network (G-I-N; www.g-i-n.net ) or the Appraisal of Guidelines Research and 
Evaluation Enterprise (AGREE; www.agreetrust.org). Perhaps the first stage would be to 
ensure that information about the work on guideline equity by INCLEN is disseminated. A 
revised AGREE II instrument has been published [27] and does not include any questions to 
help individuals appraising guidelines to examine whether the guidelines address, or make 
worse, issues of health inequity [28]. One suggestion is that future work to revise the AGREE 
instrument could incorporate issues around improving guideline equity. 
The National Guideline Clearing house website (www.guideline.gov) does not make 
reference to any guidelines specifically dedicated to the health needs and priorities of 
individuals with intellectual disabilities. Hence, it is important that more generic guidelines 
do address the health needs of people with intellectual disabilities where possible. Findings 
from this study suggest that, at present, clinical guidelines may be missing the opportunity to 
have a positive impact on the health inequities experienced by person with intellectual 
disabilities, and may even be making these worse. Content of clinical guidelines should 
endeavor to meet the five INCLEN equity lens criteria for individuals with intellectual 
disabilities and other groups. To achieve this, guidelines should recognize different disease 
patterns, including different prevalence, incidence, and etiologies; the interventions and 
supports needed by disadvantaged groups; and any necessary reasonable adjustments to 
healthcare delivery, organization, and policy in order to equally meet the needs of individuals 
with intellectual disabilities. For example, recommendations of clinical guidelines for the 
investigation of upper gastrointestinal cancers—which are more common in individuals with 
intellectual disabilities [29]—have little relevance for individuals with intellectual disabilities 
who do not have verbal communication skills if they require self-report of dyspepsia. This 
highlights the fundamental importance of clinical guidelines addressing inequities 
experienced by individuals with intellectual disabilities, recognizing the need to necessarily 
engage carers, as well as the person with intellectual disabilities in assessments and 
interventions. 
Conclusion 
Many of the issues raised with reference to intellectual disabilities are also relevant to other 
disadvantaged groups within the PROGRESS-Plus framework and should be considered by 
clinical guideline development groups. 
Most clinical guidelines do not yet meet the published equity lens criteria and may, therefore, 
be contributing to the health inequities experienced by individuals with intellectual 
disabilities and other disadvantaged groups. Therefore, contrary to the specified purpose of 
clinical guidelines, the resources devoted to clinical guideline development internationally 
may result in a widening of existing health inequities. Reasonable adjustments could be 
adopted to address this, so that the guidelines become part of a broader strategy to reduce 
health inequities. 
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